Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

When is it safe to stop contact precautions for vancomycin-resistant Enterococcus faecium carriage?

Saegeman V, Melussi P, Duerinckx R, Cossey V, Popleu L, Van der Linden L, Schuermans A.

J Hosp Infect. 2018 Jun 2. pii: S0195-6701(18)30287-1. doi: 10.1016/j.jhin.2018.05.022. [Epub ahead of print] No abstract available.

PMID:
29870750
2.

Factors impacting unbound vancomycin concentrations in neonates and young infants.

Smits A, Pauwels S, Oyaert M, Peersman N, Spriet I, Saegeman V, Allegaert K.

Eur J Clin Microbiol Infect Dis. 2018 Aug;37(8):1503-1510. doi: 10.1007/s10096-018-3277-8. Epub 2018 May 16.

PMID:
29770901
3.

A multicentre verification study of the QuantiFERON®-TB Gold Plus assay.

Pieterman ED, Liqui Lung FG, Verbon A, Bax HI, Ang CW, Berkhout J, Blaauw G, Brandenburg A, van Burgel ND, Claessen A, van Dijk K, Heron M, Hooghiemstra M, Leussenkamp-Hummelink R, van Lochem E, van Loo IHM, Mulder B, Ott A, Pontesilli O, Reuwer A, Rombouts P, Saegeman V, Scholing M, Vainio S, de Steenwinkel JEM.

Tuberculosis (Edinb). 2018 Jan;108:136-142. doi: 10.1016/j.tube.2017.11.014. Epub 2017 Nov 28.

4.

Anterior interosseous mononeuropathy associated with HEV infection.

Swinnen B, Boeynaems S, Schrooten M, Saegeman V, Claeys KG, Van Damme P.

Neurol Neuroimmunol Neuroinflamm. 2017 Dec 22;5(2):e429. doi: 10.1212/NXI.0000000000000429. eCollection 2018 Mar. No abstract available.

5.

OXA-427, a new plasmid-borne carbapenem-hydrolysing class D β-lactamase in Enterobacteriaceae.

Bogaerts P, Naas T, Saegeman V, Bonnin RA, Schuermans A, Evrard S, Bouchahrouf W, Jove T, Tande D, de Bolle X, Huang TD, Dortet L, Glupczynski Y.

J Antimicrob Chemother. 2017 Sep 1;72(9):2469-2477. doi: 10.1093/jac/dkx184.

PMID:
28859446
6.

The HUMTICK study: protocol for a prospective cohort study on post-treatment Lyme disease syndrome and the disease and cost burden of Lyme borreliosis in Belgium.

Geebelen L, Lernout T, Kabamba-Mukadi B, Saegeman V, Sprong H, Van Gucht S, Beutels P, Speybroeck N, Tersago K.

Arch Public Health. 2017 Aug 7;75:42. doi: 10.1186/s13690-017-0202-z. eCollection 2017.

7.

Performance of three generations of Xpert MRSA in routine practice: approaching the aim?

Jacqmin H, Schuermans A, Desmet S, Verhaegen J, Saegeman V.

Eur J Clin Microbiol Infect Dis. 2017 Aug;36(8):1363-1365. doi: 10.1007/s10096-017-2939-2. Epub 2017 Mar 20.

PMID:
28321579
8.

How is post-mortem microbiology appraised by pathologists? Results from a practice survey conducted by ESGFOR.

Saegeman V, Cohen MC, Alberola J, Ziyade N, Farina C; ESCMID Study Group for Forensic and Postmortem Microbiology, Cornaglia G, Fernández-Rodríguez A.

Eur J Clin Microbiol Infect Dis. 2017 Aug;36(8):1381-1385. doi: 10.1007/s10096-017-2943-6. Epub 2017 Feb 24.

PMID:
28236029
9.

Comment on "A Cluster of Three Cases of Hantavirus Pulmonary Syndrome among Canadian Military Personnel".

Clement J, Maes P, Saegeman V, Lagrou K, Van Ranst M, Lundkvist Å.

Can J Infect Dis Med Microbiol. 2016;2016:7458409. doi: 10.1155/2016/7458409. Epub 2016 Dec 20. No abstract available.

10.

Usefulness of maternal red cell antibodies to predict hemolytic disease of the fetus and newborn and significant neonatal hyperbilirubinemia: a retrospective study.

Peeters B, Geerts I, Badts AM, Saegeman V, Moerman J.

Clin Chem Lab Med. 2017 Aug 28;55(9):e202-e205. doi: 10.1515/cclm-2016-0545. No abstract available.

PMID:
28076300
11.

Analytical and clinical comparison of Elecsys syphilis (Roche®) - Architect syphilis TP and reformulated Architect syphilis TP (Abbott®) assay.

De Keukeleire S, Desmet S, Lagrou K, Oosterlynck J, Verhulst M, Van Besien J, Saegeman V, Reynders M.

Diagn Microbiol Infect Dis. 2017 Mar;87(3):210-212. doi: 10.1016/j.diagmicrobio.2016.12.003. Epub 2016 Dec 9.

PMID:
28012638
12.

Diagnostic Challenges and Clinical Characteristics of Hepatitis E Virus-Associated Guillain-Barré Syndrome.

Stevens O, Claeys KG, Poesen K, Saegeman V, Van Damme P.

JAMA Neurol. 2017 Jan 1;74(1):26-33. doi: 10.1001/jamaneurol.2016.3541.

PMID:
27820624
13.

How to treat a fulminant erysipelas and sepsis caused by Myroides odoratimimus: case report and literature review.

Willems P, Muller J, Verhaegen J, Saegeman V, Desmet S.

Acta Clin Belg. 2017 Oct;72(5):331-335. doi: 10.1080/17843286.2016.1245173. Epub 2016 Oct 20. Review.

PMID:
27765000
14.

Streptococcus Gallolyticus Subsp. Pasteurianus Infection In A Neonatal Intensive Care Unit.

Saegeman V, Cossey V, Loens K, Schuermans A, Glaser P.

Pediatr Infect Dis J. 2016 Nov;35(11):1272-1275.

PMID:
27355933
15.

Letter to the editor: The first tick-borne encephalitis case in the Netherlands: reflections and a note of caution.

Clement J, Lagrou K, Saegeman V, Maes P, van Ranst M.

Euro Surveill. 2016 Sep 29;21(39). doi: 10.2807/1560-7917.ES.2016.21.39.30355. No abstract available.

16.

Technical and clinical validation of three commercial real-time PCR kits for the diagnosis of neuroborreliosis in cerebrospinal fluid on three different real-time PCR platforms.

Maes L, Carolus T, De Preter V, Ignoul S, Cartuyvels R, Braeken L, D'Huys PJ, Saegeman V, Kabamba B, Raymaekers M.

Eur J Clin Microbiol Infect Dis. 2017 Feb;36(2):273-279. doi: 10.1007/s10096-016-2797-3. Epub 2016 Oct 6.

PMID:
27714590
17.

Adherence to infection control guidelines in surgery on MRSA positive patients : A cost analysis.

Saegeman V, Schuermans A.

Acta Orthop Belg. 2016 Sep;82(3):663-667.

PMID:
29119911
18.

Binary toxin and its clinical importance in Clostridium difficile infection, Belgium.

Pilate T, Verhaegen J, Van Ranst M, Saegeman V.

Eur J Clin Microbiol Infect Dis. 2016 Nov;35(11):1741-1747. Epub 2016 Jul 8.

PMID:
27393490
19.

Nontuberculous mycobacteria among pulmonary tuberculosis patients: a retrospective Belgian multicenter study.

De Keukeleire S, Mathys V, Van den Wijngaert S, Van De Vyvere M, Jonckheere S, De Beenhouwer H, De Bel A, Arrazola de Onate W, Wanlin M, Piérard D, Nulens E, Saegeman V.

Acta Clin Belg. 2017 Feb;72(1):45-48. doi: 10.1080/17843286.2016.1200823. Epub 2016 Jun 24.

PMID:
27345031
20.

Are hantavirus infections also part of the rapidly growing spectrum of an infection-triggered reactive haemophagocytic syndrome?

Clement J, Colson P, Saegeman V, Lagrou K, Van Ranst M.

Clin Microbiol Infect. 2016 Aug;22(8):745-6. doi: 10.1016/j.cmi.2016.05.018. Epub 2016 Jun 2. No abstract available.

21.

Development of a national EUCAST challenge panel for antimicrobial susceptibility testing.

Desmet S, Verhaegen J, Glupzcynski Y, Van Eldere J, Melin P, Goossens H, Piérard D, Declercq P, Lagrou K, Boel A, Cartuyvels R, Denis O, Vandewal W, Saegeman V.

Clin Microbiol Infect. 2016 Aug;22(8):704-10. doi: 10.1016/j.cmi.2016.05.011. Epub 2016 May 24.

22.

Q fever: a contemporary case series from a Belgian hospital.

Vanderbeke L, Peetermans WE, Saegeman V, De Munter P.

Acta Clin Belg. 2016 Apr 27:1-7. [Epub ahead of print]

PMID:
27118360
23.

'Bedside assessment' of acute hantavirus infections and their possible classification into the spectrum of haemophagocytic syndromes.

Clement J, Colson P, Saegeman V, Lagrou K, Van Ranst M.

Eur J Clin Microbiol Infect Dis. 2016 Jul;35(7):1101-6. doi: 10.1007/s10096-016-2638-4. Epub 2016 Apr 21.

PMID:
27101352
24.

Typing of Pneumocystis jirovecii by multilocus sequencing: evidence of outbreak?

Depypere M, Saegeman V, Lagrou K.

Eur J Clin Microbiol Infect Dis. 2016 Jun;35(6):911-6. doi: 10.1007/s10096-016-2615-y. Epub 2016 Apr 1.

PMID:
27038443
25.

Post-test probability for neonatal hyperbilirubinemia based on umbilical cord blood bilirubin, direct antiglobulin test, and ABO compatibility results.

Peeters B, Geerts I, Van Mullem M, Micalessi I, Saegeman V, Moerman J.

Eur J Pediatr. 2016 May;175(5):651-7. doi: 10.1007/s00431-016-2690-1. Epub 2016 Jan 19.

PMID:
26782094
26.

Aeromonas Associated With Swimming Pool Folliculitis.

Saegeman V, Van Meensel B.

Pediatr Infect Dis J. 2016 Jan;35(1):118-9. doi: 10.1097/INF.0000000000000940. No abstract available.

PMID:
26741585
27.

Cronobacter sakazakii bacteremia in a heart transplant patient with polycystic kidney disease.

Tamigniau A, Vanhaecke J, Saegeman V.

Transpl Infect Dis. 2015 Dec;17(6):921-5. doi: 10.1111/tid.12466. Epub 2015 Nov 25.

PMID:
26436411
28.

Case report of a false positive result of the Xpert® MTB/RIF assay for rifampicin resistance in Mycobacterium tuberculosis complex.

Claessens J, Mathys V, Derdelinckx I, Saegeman V.

Acta Clin Belg. 2017 Jun;72(3):195-197. doi: 10.1179/2295333715Y.0000000072. Epub 2016 Jun 10.

PMID:
26400761
29.

Tracing delays in infection control measures in a nosocomial norovirus outbreak.

Saegeman V, Popleu L, Cossey V, Schuermans A.

J Hosp Infect. 2015 Nov;91(3):286-7. doi: 10.1016/j.jhin.2015.06.022. Epub 2015 Aug 22. No abstract available.

PMID:
26364209
30.

How to isolate a patient with Cladophialophora bantiana infection? An opinion.

Saegeman V, Bammens B, De Munter P, Neyt J, Cossey V, Schuermans A.

J Hosp Infect. 2015 Sep;91(1):89-90. doi: 10.1016/j.jhin.2015.05.005. Epub 2015 Jun 9. No abstract available.

PMID:
26122625
31.

Performance of different culture methods and of a commercial molecular assay for the detection of carbapenemase-producing Enterobacteriaceae in nursing homes and rehabilitation centers.

Saegeman V, Van den Eynde J, Niclaes L, De Ridder D, Schuermans A, Glupczynski Y.

Eur J Clin Microbiol Infect Dis. 2015 May;34(5):991-7. doi: 10.1007/s10096-015-2318-9. Epub 2015 Jan 21.

PMID:
25698310
32.

How to optimise the yield of forensic and clinical post-mortem microbiology with an adequate sampling: a proposal for standardisation.

Fernández-Rodríguez A, Cohen MC, Lucena J, Van de Voorde W, Angelini A, Ziyade N, Saegeman V.

Eur J Clin Microbiol Infect Dis. 2015 May;34(5):1045-57. doi: 10.1007/s10096-015-2317-x. Epub 2015 Feb 14.

PMID:
25680317
33.

Prospective validation of neonatal vancomycin dosing regimens is urgently needed.

Vandendriessche A, Allegaert K, Cossey V, Naulaers G, Saegeman V, Smits A.

Curr Ther Res Clin Exp. 2014 Jul 14;76:51-7. doi: 10.1016/j.curtheres.2014.06.001. eCollection 2014 Dec.

34.

Comparison of two automated immunoassays for the determination of Puumalavirus IgM and IgG.

Muyldermans A, Lagrou K, Patteet S, Van Esbroeck M, Van Ranst M, Saegeman V.

J Clin Virol. 2014 Jun;60(2):165-7. doi: 10.1016/j.jcv.2014.03.009. Epub 2014 Mar 25.

PMID:
24713176
35.

Carbapenemase producing Enterobacteriaceae in Belgian nursing homes: myth or real danger?

Saegeman VS, Ntoumpanaki M, Niclaes L, Schuermans A.

Acta Clin Belg. 2014 Jan-Feb;69(1):30-2. doi: 10.1179/0001551213Z.00000000013.

PMID:
24635396
36.

Population pharmacokinetic modelling of total and unbound cefazolin plasma concentrations as a guide for dosing in preterm and term neonates.

De Cock RF, Smits A, Allegaert K, de Hoon J, Saegeman V, Danhof M, Knibbe CA.

J Antimicrob Chemother. 2014 May;69(5):1330-8. doi: 10.1093/jac/dkt527. Epub 2014 Feb 2.

PMID:
24492261
37.
38.

Invasive Aspergillus niger complex infections in a Belgian tertiary care hospital.

Vermeulen E, Maertens J, Meersseman P, Saegeman V, Dupont L, Lagrou K.

Clin Microbiol Infect. 2014 May;20(5):O333-5. doi: 10.1111/1469-0691.12394. Epub 2013 Nov 4.

39.

Paecilomyces lilacinus and alternaria infectoria cutaneous infections in a sarcoidosis patient after double-lung transplantation.

Saegeman VS, Dupont LJ, Verleden GM, Lagrou K.

Acta Clin Belg. 2012 May-Jun;67(3):219-21.

PMID:
22897073
40.

Management of macrolide-resistant Mycoplasma pneumoniae infection.

Saegeman V, Proesmans M, Dumke R.

Pediatr Infect Dis J. 2012 Nov;31(11):1210-1. doi: 10.1097/INF.0b013e3182611cee. No abstract available.

PMID:
22668803
41.
42.

Clinical evaluation of the Copan ESwab for methicillin-resistant Staphylococcus aureus detection and culture of wounds.

Saegeman V, Flamaing J, Muller J, Peetermans WE, Stuyck J, Verhaegen J.

Eur J Clin Microbiol Infect Dis. 2011 Aug;30(8):943-9. doi: 10.1007/s10096-011-1178-1. Epub 2011 Feb 6.

PMID:
21298460
43.

Increasing incidence of mucormycosis in University Hospital, Belgium.

Saegeman V, Maertens J, Meersseman W, Spriet I, Verbeken E, Lagrou K.

Emerg Infect Dis. 2010 Sep;16(9):1456-8. doi: 10.3201/eid1609.100276.

44.

Should gender-related reference values be used for total bilirubin?

Saegeman VS, Vierendeels I, Moens MJ, Moerman J.

Clin Chem Lab Med. 2009;47(10):1309-10. doi: 10.1515/CCLM.2009.282. No abstract available.

PMID:
19751143
45.

Epidemiology of mucormycosis: review of 18 cases in a tertiary care hospital.

Saegeman V, Maertens J, Ectors N, Meersseman W, Lagrou K.

Med Mycol. 2010 Mar;48(2):245-54. doi: 10.1080/13693780903059477.

PMID:
19568978
46.

Effectiveness of antibiotics and antiseptics on coagulase-negative staphylococci for the decontamination of bone allografts.

Saegeman VS, Ectors NL, Lismont D, Verduyckt B, Verhaegen J.

Eur J Clin Microbiol Infect Dis. 2009 Jul;28(7):813-6. doi: 10.1007/s10096-009-0715-7. Epub 2009 Mar 10.

PMID:
19277735
47.

EATB Donor Case Workshop 2007.

Saegeman VS, Chandrasekar A, van Wijk MJ, Beele H, Montenero MM, Navarro A, Van Geyt C, Bokhorst AG, Fehily D, Warwick RM; EATB Donor Case Workshop Working Group.

Cell Tissue Bank. 2009 Nov;10(4):351-7. doi: 10.1007/s10561-009-9125-4. Epub 2009 Feb 18.

PMID:
19224394
48.

Transfusion-induced serum sickness.

Saegeman V, Wynendaele W, Kerre S, Dedeurwaerdere F, Van den Driessche M, Moerman J.

Transfusion. 2009 Feb;49(2):372-45. doi: 10.1111/j.1537-2995.2008.01956.x. Epub 2008 Oct 28.

PMID:
18980620
49.

Bacteriostasis testing on allograft tissue inoculated in Wilkins-Chalgren broth.

Saegeman V, Ectors N, Lismont D, Verduyckt B, Verhaegen J.

J Hosp Infect. 2008 Nov;70(3):278-83. doi: 10.1016/j.jhin.2008.07.020.

PMID:
18799239
50.

Influence of postmortem time on the outcome of blood cultures among cadaveric tissue donors.

Saegeman V, Verhaegen J, Lismont D, Verduyckt B, De Rijdt T, Ectors N.

Eur J Clin Microbiol Infect Dis. 2009 Feb;28(2):161-8. doi: 10.1007/s10096-008-0609-0. Epub 2008 Aug 16.

PMID:
18709393

Supplemental Content

Loading ...
Support Center